Proprietary secondary development of scientific and technological progress award first prize

"I hope that through our technology can transform the look of all commonly used Chinese medicine, Chinese medicine to enhance scientific and technological content, so that the ancient Chinese medicine into the ranks of modern technology." Said this man is Tianjin University of Traditional Chinese Medicine TRADITIONAL Academy of Sciences. He led the team to complete the "secondary development of proprietary core technology system, a research and industrialization" project has just won the 2014 annual National Science and Technology Progress Award.

Chinese medicine is our unique health resources, is an important national industry, has an important significance in the overall economic and social development. However, due to historical reasons, Chinese science and technology base is relatively weak, resulting in clinical medicine vague position, extensive pharmaceutical technology, quality control, backward technology, poor risk management and control processes. "These factors restrict the bigger and stronger varieties of Chinese medicine, Chinese medicine our country nearly ten thousand varieties, with annual sales of just over a hundred varieties billion, over ten million little big brands." Said Zhang Boli.

Clinical need "good medicine" industry needs "big medicine", how to cultivate a large variety of high quality and effective medicine, is an important issue in the development of the pharmaceutical industry.

Restrictive proprietary varieties bigger and stronger factor TRADITIONAL thought to include two aspects: First, the complexity of medicine itself, the second is research lag, the Human epidermal growth factor receptor ELISA Kit http://www.cusabio.com/html/product/CSB-E12124h.html of a broad clinical orientation, physical unclear efficacy, mechanism of action is unknown, extensive pharmaceutical technology, under the quality control standards.

Significant demand around the bigger and stronger proprietary varieties of traditional Chinese medicine industry to promote science and technology, and conservation-efficient transformation TRADITIONAL led the research group pioneered the secondary development of proprietary research strategy, after eight years, presented in original medicines secondary development of theory, method and technology strategy, the creation of proprietary systems engineering based secondary development model, the formation of high-tech development and the integration of traditional Chinese medicine industry characteristics make a large variety of traditional Chinese medicine are emerging.

According to Zhang Boli, the project completed a total of 32 secondary development of proprietary varieties, with sales of over billion varieties from three to 12, only a year in 2013 with sales of 50 billion, is the last year 4.6 times the total sales of more than 20 billion yuan.

"At present, the project technology has been in the country 19 provinces and cities to promote applied to hundreds of Chinese enterprises.", Said Zhang Boli, proved proprietary second development is a small investment, quick, effective way to drive innovation across the development of Chinese medicine industry not only to promote the adjustment of industrial structure, change the mode of economic development, while serving healthcare reform, benefit people's livelihood, can provide safe and effective for the prevention and treatment of major diseases, cheap drugs, to guarantee the success of health care reform, and promote the development of bio-pharmaceutical industry, will play to a major role in promoting, producing a significant economic and social benefits.